To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Ferring Pharmaceuticals is a pharmaceutical company that specializes on the development and marketing of peptides for use in human medicine. It was founded by Frederik Paulsen in Malmö, Sweden, in 1950 initially as the Nordiska Hormon Laboratoriet, renamed Ferring in 1954. A ferring in Frisian is a person from the island Föhr off the western coast of Germany. Mr. Paulsen's family originates from that island.
Additional recommended knowledge
The first major product was the synthetic production of oxytocin and vasopressin in 1961. With further growth and expansion, the headquarters moved to Copenhagen, Denmark, and subsequently to Switzerland. In 2005, the company held over 2,700 employees with manufacturing facilities in Denmark, Sweden, Germany, the Czech Republic, Switzerland and China.
Products are used in endocrinology, gastroenterology, infertility, obstetrics and gynecology, and urology.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ferring_Pharmaceuticals". A list of authors is available in Wikipedia.|